Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.

http://www.wikidata.org/entity/Q39046974

about

Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible.The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas.The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.Drug delivery by supramolecular design.Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.Opening the ventricle during surgery diminishes survival among patients with newly diagnosed glioblastoma treated with carmustine wafers: a multi-center retrospective study.Nanotherapeutic systems for local treatment of brain tumors.Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.Developing Therapies for Brain Tumors: The Impact of the Johns Hopkins Hunterian Neurosurgical Research Laboratory.Glioblastoma fed by middle meningeal artery and displaying cyst formation soon after repeated implantation of carmustine wafers: A case report.HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy.Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.iRGD-mediated core-shell nanoparticles loading carmustine and O6-benzylguanine for glioma therapy.Rationale and design of the 500-patient, 3-year, and prospective Vigilant ObservatIon of GlIadeL WAfer ImplaNT registry.Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma.Adverse Event with the Use of Carmustine Wafers and Postoperative Radiochemotherapy for the Treatment of High-grade Glioma

P2860

Q26739012-107EC28E-E841-446F-8753-766D49988699 Q28078486-95A185C4-F9F9-45BA-9AE2-8FB1D1D533BE Q35967155-7CB9F9CF-5574-4072-9363-4F91337B6A68 Q36231572-2126A2A9-5659-4923-A558-FFF97AAEB641 Q36297929-F7634849-B88A-48CC-AB9C-B99F48637949 Q36349882-A9FE1BB8-2FFB-4367-9ADD-17EF6D95192D Q36522674-25A7DB7B-7B53-45EF-BA8C-E85D9C4A0375 Q38546470-E9D2E976-36FB-42E4-B088-02D163E337E6 Q38638945-87EEFB28-8277-427B-9386-5A4C4D612243 Q38685603-0545E3F1-87E5-434F-AA5B-CAB475C8FC82 Q38769659-08788C88-839E-4858-8BEE-C1D5FC57FA0D Q39330269-E494D0B7-77DE-40FE-8C4E-C8213B1A2F84 Q40113860-6CAA8C88-DDDB-4EB9-B798-6BB92E81A064 Q40150597-5EB6DFC6-25A5-4893-867B-64D10DEA7F4C Q41112137-62D60535-911F-4BCF-90D9-D7B5CC9C96ED Q47126993-48F1FD7D-3321-4D0D-95E8-FCEDDB1DEC13 Q47385937-E9A17447-1852-449D-BBA1-B91F0BCE9D5C Q47720697-D57A7EB7-4408-4079-9729-1E4EE0D1FA31 Q48504707-92F875F3-C0B2-4C6D-9617-FC96DE29CC78 Q50071181-99C84757-AB69-4CD5-8627-449E95FAAF25 Q52142503-3CD49BC5-7690-4EAD-8517-0FBB557A7AB6 Q52677063-DFD656C6-0C9B-4015-B1A3-52ECE649934F Q59128662-BC4E64FC-FD21-4C75-BD46-51B59F138622

P2860

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.

http://www.wikidata.org/entity/Q39046974

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@en

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@nl

type

label

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@en

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@nl

prefLabel

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@en

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@nl

P1433

Q39046974-3679988F-9990-4701-BFD3-8A3A8996BF6B

P1476

Q39046974-FAA08E86-355A-4B6E-9DB5-60555DE2B721

P2093

Q39046974-4E39A369-1093-4242-A05A-FDB26280262B

Q39046974-88163B8A-5374-4B7B-AB9B-F7E33684DE3B

Q39046974-EE7AFA46-127A-4C4E-98C8-EFA7C77B0F28

P2860

Q39046974-0205C4D3-C6E6-475C-8A3D-C450AF1C8FD5

Q39046974-075293A1-A845-47DE-861D-68D31826A24D

Q39046974-0A06BE0D-6E95-4FBB-903E-0E8079DEC0E4

Q39046974-0A1304CC-FC0F-4110-B887-9959E75D1E65

Q39046974-0A48F9F0-491D-4BE5-89C2-BA3AA09625B6

Q39046974-0B69B269-81B0-453B-B27F-D19FE7FCF474

Q39046974-0CB4E597-5B84-4AFE-A171-9AF3ACAA1BE0

Q39046974-0EC6F92E-BE4E-4BD1-8761-DE2BB3A9608A

Q39046974-0F288793-95F8-48B7-B3F5-96E94FB8E04A

Q39046974-115282C6-7309-43F9-8455-2A793AC99FB9

P2888

Q39046974-77B3158F-E85E-472E-A521-DAB0B1634138

P304

Q39046974-9DD1E747-9F82-44ED-AADA-EF271AB83CFA

P31

Q39046974-A4F27E7E-4233-486D-9C7C-7F20AC223D06

Q39046974-c0fc101f-3ae8-4bc7-a4bd-dd80d75afdcc

P356

Q39046974-8A3CF3E4-61CE-4073-B901-5E27C335E367

P433

Q39046974-53B71478-9068-4213-9C05-78145F8BD88D

P478

Q39046974-9A7BB16D-2731-4C55-B153-1BF3DD4F5FF2

P577

Q39046974-BC47729E-2D2A-4C74-A6D4-E3F9E7AB1A84

P5875

Q39046974-630813F3-19D6-4C9D-A8EA-E326F6172666

P698

Q39046974-7269A1FB-2AA5-4981-990B-F472FFA74369

P921

Q39046974-644E3FF6-75E0-4C7E-80EF-D482CD2268BC

P932

Q39046974-F665872E-6216-4B25-AF24-4C8A3D6606F8

P356

S11060-015-1724-2

P1433

Journal of Neuro-Oncology

P1476

Survival outcomes and safety o ...... rade gliomas: a meta-analysis.

@en

P2093

Herbert B Newton

http://www.w3.org/2001/XMLSchema#string

Sajeel A Chowdhary

http://www.w3.org/2001/XMLSchema#string

Timothy Ryken

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy wafers for high grade glioma

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Prognostic stratification of patients with anaplastic gliomas according to genetic profile.

Gliadel wafers in the treatment of malignant glioma: a systematic review.

Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.

Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.

Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.

Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

P2888

s11060-015-1724-2

P304

367-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-015-1724-2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

271597449

http://www.w3.org/2001/XMLSchema#string

P698

25630625

http://www.w3.org/2001/XMLSchema#string

P921

P932

4368843

http://www.w3.org/2001/XMLSchema#string